Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR-82.6%
5Y CAGR-89.0%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-82.6%/yr
Annual compound
5Y CAGR
-89.0%/yr
Recent acceleration
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 2.12 | -86.8% |
| 2023 | 16.01 | +58.0% |
| 2022 | 10.14 | -97.5% |
| 2021 | 403.98 | -99.2% |
| 2020 | 50764.56 | -60.8% |
| 2019 | 129531.14 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |